全文获取类型
收费全文 | 594篇 |
免费 | 26篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 17篇 |
妇产科学 | 4篇 |
基础医学 | 82篇 |
口腔科学 | 21篇 |
临床医学 | 50篇 |
内科学 | 103篇 |
皮肤病学 | 2篇 |
神经病学 | 49篇 |
特种医学 | 35篇 |
外科学 | 111篇 |
综合类 | 6篇 |
预防医学 | 66篇 |
眼科学 | 4篇 |
药学 | 26篇 |
中国医学 | 5篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 5篇 |
2022年 | 9篇 |
2021年 | 22篇 |
2020年 | 13篇 |
2019年 | 18篇 |
2018年 | 21篇 |
2017年 | 9篇 |
2016年 | 17篇 |
2015年 | 18篇 |
2014年 | 28篇 |
2013年 | 32篇 |
2012年 | 52篇 |
2011年 | 50篇 |
2010年 | 27篇 |
2009年 | 25篇 |
2008年 | 28篇 |
2007年 | 35篇 |
2006年 | 31篇 |
2005年 | 27篇 |
2004年 | 20篇 |
2003年 | 19篇 |
2002年 | 12篇 |
2001年 | 3篇 |
1999年 | 5篇 |
1998年 | 5篇 |
1997年 | 2篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 6篇 |
1979年 | 10篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1924年 | 1篇 |
排序方式: 共有620条查询结果,搜索用时 15 毫秒
141.
Hautamäki MP Aho AJ Alander P Rekola J Gunn J Strandberg N Vallittu PK 《Acta orthopaedica》2008,79(4):555-564
142.
143.
144.
145.
Harini A. Chakkera Glenn M. Chertow Ann M. O'Hare William J. Amend Jr. Thomas A. Gonwa 《Clinical journal of the American Society of Nephrology》2009,4(1):152-159
Background and objectives: Clinical outcomes after kidney transplant have improved considerably in the United States over the past several decades. However, the degree to which this has occurred uniformly across the country is unknown.Design, setting, participants, & measurements: Regional variations in graft failure after kidney transplant during three different time periods were examined. These time periods were chosen to coincide with major shifts in immunosuppressant usage: Era 1, cyclosporine usage, 1988 through 1989; Era 2, introduction of tacrolimus and mycophenolate mofetil, 1994 through 1995; and Era 3, widespread use of tacrolimus and mycophenolate mofetil, 1998 through 1999. Patient data were obtained from the United States Renal Data System database. For each period, regional differences in time from transplant to graft failure (organ removal, death, or return to dialysis) were examined. For each region, differences in graft failure over time were examined.Results: One-year graft survival rates ranged from 76% to 83% between regions in Era 1 (n = 13,669), from 84% to 89% in Era 2 (n = 17,456), and from 87.5% to 92% in Era 3 (n = 20,375). Three-year graft survival ranged from 65% to 75% between regions in Era 1, from 84% to 89% in Era 2, and from 77% to 86% in Era 3. Adjusted models for donor and recipient characteristics showed improvements in graft survival over time in all United Network for Organ Sharing regions with minimal variation across regions.Conclusions: Regional differences in graft survival after kidney transplant are minimal, particularly when compared with the dramatic improvements in graft survival that have occurred over time.Regional variations in health outcomes have been described in a wide variety of health care settings and are often attributed to variations in practice patterns (1–11). For kidney transplant patients, there are known regional differences in wait-list mortality, access to deceased-donor kidneys, and time to transplant (2,12). However, relatively little is known about regional variation in outcomes after kidney transplant and whether known improvements in graft survival that have occurred over time have occurred uniformly across all regions of the United States.Graft failure after kidney transplant across all United Network for Organ Sharing (UNOS) regions and within each region over time were examined. It was hypothesized that graft failure would vary by region and that these variations would have become less pronounced over time. 相似文献
146.
Bender NK Heilig CE Dröll B Wohlgemuth J Armbruster FP Heilig B 《Rheumatology international》2007,27(3):269-274
To assess the immunogenicity of adalimumab, a human anti-TNF-α mAb, we evaluated the formation of antibodies to adalimumab,
efficacy and adverse events among 15 patients with highly active rheumatoid arthritis. Four patients were treated with adalimumab
as monotherapy, and 11 patients with concomitant DMARDs. Disease activity was measured by DAS28. The antibodies were detected
by ELISA. Thirteen (87%) patients withdrew from therapy within 45 weeks and overall 13 (87%) patients showed antibodies to
adalimumab including 11 patients who withdrew from therapy. In four patients without concomitant DMARDs and in nine patients
with concomitant DMARDs, we detected anti-adalimumab antibodies. Overall, five of seven patients with adverse drug reactions
and all nine patients with lack of efficacy were associated with the formation of antibodies. Two antibody-positive patients
developed an exantheme. The results indicate that adalimumab is, in spite of its fully human sequences, immunogenic and induces
antibodies in a high rate of adalimumab-treated patients. 相似文献
147.
Niko A. Kaciroti M. Anthony Schork Trivellore Raghunathan Stevo Julius 《Statistics in medicine》2009,28(4):572-585
Intention‐to‐treat (ITT) analysis is commonly used in randomized clinical trials. However, the use of ITT analysis presents a challenge: how to deal with subjects who drop out. Here we focus on randomized trials where the primary outcome is a binary endpoint. Several approaches are available for including the dropout subject in the ITT analysis, mainly chosen prior to unblinding the study. These approaches reduce the potential bias due to breaking the randomization code. However, the validity of the results will highly depend on untestable assumptions about the dropout mechanism. Thus, it is important to evaluate the sensitivity of the results across different missing‐data mechanisms. We propose here a Bayesian pattern‐mixture model for ITT analysis of binary outcomes with dropouts that applies over different types of missing‐data mechanisms. We introduce a new parameterization to identify the model, which is then used for sensitivity analysis. The parameterization is defined as the odds ratio of having an endpoint between the subjects who dropped out and those who completed the study. Such parameterization is intuitive and easy to use in sensitivity analysis; it also incorporates most of the available methods as special cases. The model is applied to TRial Of Preventing HYpertension. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
148.
This article is an attempt to bring outdoor training and and Sociodrama closer together by creating a common frame of reference. The main idea is that the genuine stimuli provided by outdoor scenarios can enhance sociodramatic work, especially in large groups predominant within organisational cultures not otherwise open to “playing games”. In this case the example of a typical outdoor scenario of a mountain rescue exercise highlights significant aspects of what makes outdoor training work and correlates them to similar characteristics of psychodrama, in order to further understanding between the two disciplines. 相似文献
149.
Sik-Nin Wong Niko Kei-Chiu Tse Kwok-Piu Lee So-Fun Yuen Lettie Chuk-Kwan Leung Benjamin Chee-Kit Pau Winnie Kwai-Yu Chan Kwok-Wai Lee Hon-Ming Cheung Stella Chim Cynthia Mung-Sze Yip 《Pediatric nephrology (Berlin, Germany)》2010,25(10):2083-2091
We conducted a retrospective multicenter review to estimate the prevalence of urological abnormalities in Chinese children with first febrile urinary tract infection (UTI) and to evaluate the selective imaging strategy recommended by the NICE guideline for detecting underlying abnormalities. Atypical UTI was defined as in the NICE UTI guideline. Overall, 576 boys and 244 girls aged below 24 months were reviewed. All underwent ultrasound (US) and micturating cystourethrogram (MCUG) and 612 underwent DMSA scans. US was abnormal in 73 (8.9%) and vesicoureteral reflux was shown in 195 patients (23.8%). A total of 126 patients were considered to have remediable urological abnormalities requiring additional surgical or medical interventions. The NICE guideline yielded excellent negative predictive values (NPV) of 100–94.4% in girls but 91% in boys. If all boys underwent US and DMSA and only those with atypical UTI or abnormal US or DMSA proceeded to MCUG, then the NPV increased to 95.2% and 97.4% for boys aged below and above 6 months, respectively. These revised strategies would substantially save invasive studies—DMSA and MCUG in 27 and 74% of girls aged below and above 6 months, respectively, or MCUG in 23 and 59% of boys aged below and above 6 months, respectively. 相似文献
150.